FGF11 and nasopharyngeal carcinoma: Relatedly, nasopharyngeal carcinoma (NPC) exosomal miR-243 targeted FGF11 to inhibit T cell proliferation and induce Tregs to not only differentiate, but also impair T cell function (99).